Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.
Journal: Antimicrobial agents and chemotherapy
Published: April 22, 2016
A Randomized, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Ceftazidime-Avibactam in Healthy Chinese Subjects.
Journal: Clinical drug investigation
Published: December 10, 2015
Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects.
Journal: International journal of clinical pharmacology and therapeutics
Published: July 09, 2015
Randomized pharmacokinetic and drug-drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects.
Journal: Pharmacology research & perspectives
Published: June 23, 2015
An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
Journal: International journal of antimicrobial agents
Published: April 02, 2015
Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteers.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: February 12, 2015
Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens.
Journal: The Journal of antimicrobial chemotherapy
Published: December 08, 2014
Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potential.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: March 12, 2014
Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume.
Journal: British journal of clinical pharmacology
Published: February 04, 2014
Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam.
Journal: Journal of clinical pharmacology
Published: August 15, 2013
A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock.
Journal: Critical care (London, England)
Published: October 24, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026